EE279 A Systematic Literature Review of the Economic Burden in Patients with Myelodysplastic Syndrome

Abstract

Patients with higher-risk myelodysplastic syndromes (HR-MDS), if left untreated have lower overall survival and increased economic burden. This systematic literature review (SLR) identified comprehensive evidence on the economic burden of disease among patients with low-to-high risk MDS. Methodology: Literature search of English publications from 2011-2021 was conducted in Embase®, MEDLINE® and MEDLINE-In-process, including relevant conference proceedings to identify economic burden of MDS that fulfilled pre-defined inclusion criteria.